Dilemmas over tobacco research

The Lancet

Volumn 371, Issue 9610, 2008, Pages 368-370

  Gray, Nigel J ^a  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CARCINOGENICITY; CIGARETTE SMOKING; COOPERATION; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH HAZARD; HUMAN; LAW; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; TOBACCO INDUSTRY; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 38649141802     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60182-8     Document Type: Note

References (4)

1. Wilde A., and Mathews V. Philip Morris gears up for regulation. Wall Street J (June 21, 2007) A1
2. Written statement of Mike Szymanczyk, Chairman and Chief Executive Officer, Philip Morris USA (Feb 27, 2007). http://www.philipmorrisusa.com/en/our_initiatives/downloads/pdf/Health_Education_Labor_Pensions_Written_Testimony.pdf (accessed Oct 4, 2007).
3. Schick S., and Glantz S. Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement. Tob Control 16 (2007) 157-164
4. WHO Study Group on Tobacco Product Regulation. Scientific basis of tobacco product regulation (Jan 1, 2007). http://www.who.int/tobacco/global_interaction/tobreg/9789241209458.pdf (accessed Jan 28, 2008).